Inovyn, a joint-venture between Ineos and Solvay, announced details of its new chloromethanes operations strategy in response to the decline in European demand.
With effect from March 1 2016, production will be focused on Inovyn’s chloromethanes assets at Tavaux (France) and Rosignano (Italy). This will result in closure of the company’s third chloromethanes asset at Runcorn (UK).
Comments Chris Tane, CEO, Inovyn: “Our new operations strategy will ensure we are best positioned to focus on and meet the demand for chloromethanes in our core markets.
“It will also significantly improve our cost base and help underpin our sustainable, competitive position as a European chloromethanes producer.”
Inovyn will continue to offer a full range of methylene chloride grades – including its exclusive brand Methoklonetm – as well as chloroform, carbon tetrachloride and perchloroethylene.